This inventor holds 8 USPTO granted patents, plus 1 CIPO patent. Top assignees: Roussel Uclaf, Aventis Pharma S.a., Hoechst Marion Roussel. Active years: 1997-2014.
Company Filing History:
4 out of 854 
3 out of 377 
1 out of 236 Years Active: 1997-2014
Title: The Innovations of Sergio Roman-Roman
Introduction
Sergio Roman-Roman is a notable inventor based in Paris, France. He has made significant contributions to the field of biotechnology, particularly in the area of T lymphocyte receptors. With a total of 8 patents to his name, his work has had a profound impact on diagnostic and therapeutic applications.
Latest Patents
Among his latest patents is a groundbreaking invention titled "Nucleotide sequence coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses." This invention relates to new nucleotide sequences that code for variable regions of β chains of human T lymphocyte receptors, along with their corresponding peptide segments and their diagnostic and therapeutic applications. This innovative work showcases his dedication to advancing medical science.
Career Highlights
Throughout his career, Sergio has worked with prominent companies such as Roussel Uclaf and Aventis Pharma S.A. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to significant advancements in biotechnology.
Collaborations
Sergio has had the opportunity to work alongside esteemed colleagues, including Thierry Hercend and Frederic Triebel. These collaborations have further enriched his research and innovation efforts.
Conclusion
Sergio Roman-Roman's contributions to the field of biotechnology through his patents and collaborations highlight his role as a key innovator. His work continues to influence the development of diagnostic and therapeutic solutions in medicine.